Friday, August 22, 2014
Inquirer Daily News

Archive: July, 2013

Patient #1 finds out just how far he can push his body on the road to recovery

Tuesday, July 30, 2013, 9:53 AM
Two contradictory things I have constantly heard since this odyssey began were that I need rest, and I need to stay active to build my body back up. Taking it easy and pushing myself a bit. Sounds like a fun moving target to hit, eh? “Do enough to stimulate healing, but don’t do too much... Read more

God, prayer, and cancer

Thursday, July 18, 2013, 9:41 AM
So when you are faced with the reminder that life is short, and can be much too short, what do you do when the reality of discovering if there is an afterlife becomes a looming possibility? Obviously, the first concern is keeping the grim reaper at bay for as long as possible, through whatever methods... Read more

Exhaling after verifying the scan results

Tuesday, July 9, 2013, 9:50 AM
So the initial results were verified and guess what? In a few days, my tumors went from being “about 30 percent less” to 46 percent shrinkage. Pretty amazing, huh – 14 percent in one weekend! At this rate, we’ll be cancer free before Labor Day! As Lee Corso says, “Not... Read more

Is Patient #1 finally cancer-free?

Monday, July 1, 2013, 9:49 AM
After writing forty-some blog posts, the one that REALLY matters should be a breeze, right? Just tell everyone if PD-1 worked, or if it is on to Plan C – easy, huh? As with everything during this almost-yearlong odyssey, things aren’t always as easy as they seem. Friday morning, we got... Read more
About this blog
T.J. Sharpe is sharing his fight against Stage 4 Melanoma. A South Jersey native and Bishop Eustace graduate, he currently lives in Fort Lauderdale, FL with his wife Jennifer and children Josie and Tommy. He was Patient #1 in a clinical trial at Moffitt Cancer Center in Tampa as the first person worldwide to use this sequence of treatments to fight melanoma, and is currently in a second clinical trial at Holy Cross Hospital in Fort Lauderdale receiving Merck’s anti-PD-1 drug Lambrolizumab

The Patient #1 blog will update the progress of T.J.'s fight against cancer, and also touch on many cancer-related topics.

Follow T.J. on Twitter and Facebook. Reach T.J. at Patient1@tjsharpe.com.

T.J. Sharpe
Also on Philly.com:
Stay Connected